Purdue’s opioid settlement bid splits US states

Purdue said to be offering up to $12bn to settle opioid laws...

EU Pharmaceutical Law Forum

DIG DEEPER INTO CUTTING EDGE TOPICS

Will plausibility reign supreme in Lyrica second medical use...

Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.

2018 Off-Label Regulatory Compliance Congress

Explore the Ever-Changing Regulatory Landscape

Responding to the Opioid Crisis: Litigation, Regulation &amp...

There are numerous pharmaceutical and plaintiff conferences on the opioid crisis, but none that cover the legal and regulatory aspects from BOTH sides of litigation.